Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹2054 Cr.
Stock P/E
125.1
P/B
10.4
Current Price
₹1078.7
Book Value
₹ 104.2
Face Value
10
52W High
₹1309.6
52W Low
₹ 371.2
Dividend Yield
0%

Anondita Medicare Overview

Business

Anondita Medicare Ltd., operating in the Household & Personal Products sector in India, is primarily engaged in the manufacturing, marketing, and distribution of consumer goods. Given its name "Medicare," the company likely focuses on personal care products with an emphasis on health, hygiene, or wellness attributes (e.g., antiseptic soaps, sanitizers, specific skincare, or other health-oriented personal hygiene items). The core business model is typical of a Fast-Moving Consumer Goods (FMCG) company: producing high-volume, frequently purchased products and distributing them through various retail channels to a broad consumer base. The company makes money by selling these products to consumers, generating revenue from their sales margins.

Revenue Mix

Specific segment data for Anondita Medicare Ltd. is not publicly available or provided. However, within the Household & Personal Products industry, potential segments for the company could include:

Personal Hygiene & Wellness: Products like soaps, hand washes, sanitizers, intimate hygiene products, or specialized skincare.

Household Care: Potentially extending to household cleaning or germ-protection products if their "Medicare" focus extends to the home environment.

Without specific disclosures, the exact revenue contribution from any potential segments remains unknown.

Industry

The Indian Household & Personal Products industry is highly competitive, characterized by the presence of large multinational corporations (MNCs) like Unilever, Procter & Gamble, and Colgate-Palmolive, as well as strong domestic players such as Dabur, Marico, Godrej Consumer Products, and ITC. These players benefit from significant brand recognition, extensive distribution networks, and substantial marketing budgets. Anondita Medicare Ltd., being a company operating within this landscape, likely positions itself either in specific niche product categories (e.g., targeting particular health concerns), specific regional markets where it has stronger penetration, or by offering products at competitive price points. It would compete against both the established giants in specific categories and numerous other regional or local manufacturers.

MOAT

For a company of its likely scale in a competitive industry, durable competitive advantages can be challenging to build. Potential sources of moat for Anondita Medicare Ltd. could include:

Niche Product Focus: If it has developed unique, effective formulations or products within a specific health/hygiene segment that cater to unmet consumer needs.

Regional Distribution Strength: A strong, cost-effective distribution network in specific geographies where it operates, allowing better market penetration than competitors.

Cost Efficiency: Ability to manufacture and distribute certain products at a lower cost than rivals, allowing for competitive pricing while maintaining margins.

Brand Loyalty (Niche): Building a degree of trust and loyalty within its target consumer segment for its specific range of health/hygiene products.

However, establishing a significant, wide-reaching moat like those possessed by large incumbents (e.g., massive brand equity, unparalleled scale economies) would be difficult.

Growth Drivers

Key factors that can drive growth for Anondita Medicare Ltd. over the next 3-5 years include:

Increasing Health & Hygiene Awareness: Growing consumer focus on hygiene, preventive healthcare, and wellness, especially post-pandemic, creating demand for relevant products.

Rising Disposable Incomes: Enabling consumers to spend more on personal care and household products, including premium offerings.

Urbanization & Premiumization: Expansion into tier 2/3 cities and a trend towards higher-value, specialized products.

Distribution Expansion: Deepening reach into untapped rural markets and leveraging modern retail and e-commerce channels.

Product Innovation: Introducing new products, variants, or improved formulations that address evolving consumer needs and preferences.

Risks

Intense Competition: The market is crowded with well-entrenched players, making it challenging to gain market share and sustain pricing power.

Raw Material Price Volatility: Fluctuations in prices of key ingredients (e.g., chemicals, packaging materials, fragrances) can impact production costs and margins.

Changing Consumer Preferences: Rapid shifts in consumer tastes, trends, and loyalty require constant product innovation and marketing adaptation.

Regulatory Scrutiny: Compliance with evolving product safety, quality, labeling, and advertising regulations in the FMCG and health products sector.

Distribution Challenges: Maintaining and expanding an efficient distribution network across diverse Indian markets can be complex and costly.

Brand Dilution/Recall: Limited brand investment compared to larger players could hinder recall and loyalty.

Management & Ownership

Specific details regarding Anondita Medicare Ltd.'s promoters, management quality, and ownership structure are not provided. Typically, Indian companies of this nature are promoter-driven, with significant ownership held by the founding family or individuals. The quality of management would depend on their experience, strategic vision, execution capabilities, and commitment to corporate governance, which cannot be assessed without further information.

Outlook

Anondita Medicare Ltd. operates in the resilient and growing Indian Household & Personal Products market, which benefits from demographic tailwinds, increasing disposable incomes, and heightened health awareness. The potential for growth, particularly in niche health and hygiene segments, is favorable. However, the company faces formidable competition from established domestic and international players with extensive resources, brand equity, and distribution networks. Its ability to thrive will largely depend on a focused strategy, consistent product innovation, effective brand building within its chosen niches, and efficient expansion of its distribution reach while managing cost pressures. Success would require strong execution to differentiate its offerings and capture market share amidst intense rivalry.

Anondita Medicare Share Price

Live · NSE · Inception: 2024
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Anondita Medicare Quarterly Results

#(Fig in Cr.)
Net Sales
Other Income
Total Income
Total Expenditure
Operating Profit
Interest
Depreciation
Exceptional Income / Expenses
Profit Before Tax
Provision for Tax
Profit After Tax
Adjustments
Profit After Adjustments
Adjusted Earnings Per Share

Anondita Medicare Profit & Loss

#(Fig in Cr.) Mar 2025 TTM
Net Sales 77
Other Income 0
Total Income 77
Total Expenditure 51
Operating Profit 26
Interest 3
Depreciation 1
Exceptional Income / Expenses 0
Profit Before Tax 22
Provision for Tax 6
Profit After Tax 16
Adjustments -1
Profit After Adjustments 16
Adjusted Earnings Per Share 11.9

Anondita Medicare Balance Sheet

#(Fig in Cr.) Mar 2025
Shareholder's Funds 38
Minority's Interest 1
Borrowings 12
Other Non-Current Liabilities 0
Total Current Liabilities 27
Total Liabilities 78
Fixed Assets 14
Other Non-Current Assets 10
Total Current Assets 55
Total Assets 78

Anondita Medicare Cash Flow

#(Fig in Cr.) Mar 2025
Opening Cash & Cash Equivalents 0
Cash Flow from Operating Activities -10
Cash Flow from Investing Activities -23
Cash Flow from Financing Activities 33
Net Cash Inflow / Outflow -0
Closing Cash & Cash Equivalent 0

Anondita Medicare Ratios

# Mar 2025
Earnings Per Share (Rs) 11.88
CEPS(Rs) 13.05
DPS(Rs) 0
Book NAV/Share(Rs) 28.49
Core EBITDA Margin(%) 33.36
EBIT Margin(%) 32.33
Pre Tax Margin(%) 28.51
PAT Margin (%) 21.32
Cash Profit Margin (%) 22.53
ROA(%) 20.97
ROE(%) 43.35
ROCE(%) 38.15
Receivable days 126.83
Inventory Days 63.99
Payable days 39.74
PER(x) 0
Price/Book(x) 0
Dividend Yield(%) 0
EV/Net Sales(x) 0.52
EV/Core EBITDA(x) 1.56
Net Sales Growth(%) 0
EBIT Growth(%) 0
PAT Growth(%) 0
EPS Growth(%) 0
Debt/Equity(x) 0.72
Current Ratio(x) 2.03
Quick Ratio(x) 1.54
Interest Cover(x) 8.47
Total Debt/Mcap(x) 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR — — — —
Operating Profit CAGR — — — —
PAT CAGR — — — —
Share Price CAGR +190% — — —
ROE Average +43% +43% +43% +43%
ROCE Average +38% +38% +38% +38%

Anondita Medicare Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 62.4 %
FII 3.4 %
DII (MF + Insurance) 5.7 %
Public (retail) 28.5 %
# Sep 2025 Mar 2026
Promoter 61.7962.4
FII 4.243.4
DII 6.555.7
Public 27.4228.5
Others 00
Total 100100

Anondita Medicare Peer Comparison

Household & Personal Products Edit Columns

Anondita Medicare Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Anondita Medicare Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 43%
  • Debtor days have improved from 39.74 to days.
  • Company has reduced debt.

Cons

  • Stock is trading at 10.4 times its book value.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp